VALE · NYSE
| FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | |
|---|---|---|---|---|---|---|
| Total Revenue | $48.75B | $62.34B | $48.22B | $23.94B | $38.51B | $33.12B |
| Research & Development | $1.48B | $1.67B | $878.00M | $981.00M | $1.08B | $733.00M |
| Selling, General & Administrative | $2.24B | $2.33B | $1.70B | $1.13B | $1.75B | $1.25B |
| Operating Expenses | $38.47B | $30.83B | $25.33B | $17.25B | $22.68B | $19.05B |
| Operating Income | $9.22B | $30.11B | $21.70B | $6.06B | $14.75B | $13.19B |
| Other Income / (Expense) | -$3.80B | -$3.31B | -$1.38B | $1.07B | -$1.53B | $2.04B |
| Income Before Taxes | $5.42B | $26.80B | $20.31B | $7.12B | $13.22B | $15.23B |
| Provision for Income Taxes | -$833.00M | $5.28B | $3.71B | $2.10B | $535.00M | $3.20B |
| Net Income | $5.51B | $22.89B | $17.26B | $5.35B | $13.22B | $11.82B |
| Basic Shares Outstanding | — | 5.18B | 5.25B | 5.21B | 5.06M | — |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $1.90 | $1.73 | $2.22 | 5 | ↑0 ↓5 |
| Dec 2027 | $2.10 | $1.78 | $2.36 | 5 | ↑0 ↓5 |
| Dec 2028 | $2.00 | $1.53 | $2.25 | 3 | ↑0 ↓1 |
| Dec 2029 | $2.43 | $2.43 | $2.43 | 1 | ↑1 ↓0 |